Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    Tenofovir Alafenamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,658Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Biktarvy

    02 6Descovy

    03 15Genvoya

    04 8Odefsey

    05 5Prezista/Prezcobix/Rezolsta/Symtuza

    06 5Revenue share - Symtuza

    07 5Stribild

    08 7Symtuza

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Prezista/Prezcobix/Rezolsta/Symtuza

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Johnson & Johnson

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 2,184

    2019 Revenue in Millions : 2,110

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Biktarvy

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Biktarvy

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 7,259

    2019 Revenue in Millions : 4,738

    Growth (%) : 53

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Genvoya

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Genvoya

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 3,338

    2019 Revenue in Millions : 3,931

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Symtuza

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Symtuza

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 488

    2019 Revenue in Millions : 379

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Stribild

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Stribild

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 196

    2019 Revenue in Millions : 369

    Growth (%) : -47

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Odefsey

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,672

    2019 Revenue in Millions : 1,655

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Symtuza

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Symtuza

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 488

    2019 Revenue in Millions : 379

    Growth (%) : 29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Descovy

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Descovy

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,861

    2019 Revenue in Millions : 1,500

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Genvoya

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Genvoya

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 3,338

    2019 Revenue in Millions : 3,931

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Odefsey

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    arrow
    ChemOutsourcing
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    ChemOutsourcing
    Not Confirmed

    Gilead

    Bictegravir, Emtricitabine, Tenofovir Alafenamide

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 1,568

    2020 Revenue in Millions : 1,672

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF